Medeon Biodesign, Inc. (6499.TWO)
TWD 39.6
(-1.0%)
TWD 39.6
(-1.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 196.26 Million | 298.31 Million | 68.95 Million | 123.05 Million | 453.76 Million |
| Cost of Revenue | 261.46 Million | 111.5 Million | 40.32 Million | 76.75 Million | 267.51 Million |
| Gross Profit | -65.2 Million | 186.81 Million | 28.63 Million | 46.3 Million | 186.24 Million |
| Operating Expenses | 774.36 Million | 674.64 Million | 524.22 Million | 388.44 Million | 442.94 Million |
| Selling, General and Administrative Expenses | 110.44 Million | 153.02 Million | 108.35 Million | 98.5 Million | 141.99 Million |
| Research and Development Expenses | 663.91 Million | 521.62 Million | 415.87 Million | 289.94 Million | 300.94 Million |
| Other Expenses | - | -4.04 Million | -43.07 Million | -8.59 Million | -11.67 Million |
| Cost and Expenses | 1.03 Billion | 786.15 Million | 564.54 Million | 465.19 Million | 710.46 Million |
| Operating Income | -839.56 Million | -433.9 Million | -512.88 Million | -341.12 Million | -250.73 Million |
| Interest Expense | 6.64 Million | 5.21 Million | 1.02 Million | 1.38 Million | 2.73 Million |
| Income Tax Expense | 39.28 Million | 57.78 Million | 72.45 Million | 5.28 Million | 28.64 Million |
| Earnings before Tax | -1.24 Billion | -439.11 Million | -513.9 Million | -342.11 Million | -254.07 Million |
| Net Income | -1.2 Billion | -433.75 Million | 2.07 Billion | -192.73 Million | -261.98 Million |
| Earnings Per Share Basic | -13.09 | -4.71 | 22.65 | -2.10 | -2.86 |
| Earnings Per Share Diluted | -13.09 | -4.71 | 22.57 | -2.10 | -2.86 |
| Weighted Average Shares Outstanding | 92.03 Million | 92.01 Million | 91.75 Million | 91.63 Million | 91.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 92.03 Million | 92.01 Million | 92.08 Million | 91.63 Million | 91.59 Million |
| Gross Margin | -0.33 | 0.63 | 0.42 | 0.38 | 0.41 |
| EBIT Margin | -5.82 | -1.24 | -6.58 | -2.09 | -0.38 |
| Profit Margin | -6.14 | -1.45 | 30.14 | -1.57 | -0.58 |
| EBITDA | -1.14 Billion | -370.1 Million | -453.86 Million | -256.45 Million | -172.08 Million |
| Earnings Before Tax Margin | -4.28 | -1.45 | -7.44 | -2.77 | -0.55 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 63.52 Million | 47.14 Million | 55.47 Million | 45.72 Million | 51.72 Million | 43.33 Million |
| Cost of Revenue | 53.37 Million | 42.98 Million | 71.98 Million | 45.68 Million | 47.49 Million | 36.97 Million |
| Gross Profit | 10.15 Million | 4.15 Million | -16.51 Million | 36 Thousand | 4.23 Million | 6.36 Million |
| Operating Expenses | 228.99 Million | 230.45 Million | 199.83 Million | 219 Million | 204.92 Million | 209.26 Million |
| Selling, General and Administrative Expenses | 48.1 Million | 41.6 Million | 24.18 Million | 50 Million | 40.92 Million | 51.1 Million |
| Research and Development Expenses | 180.89 Million | 188.85 Million | 175.65 Million | 168.99 Million | 163.99 Million | 158.16 Million |
| Other Expenses | -1.86 Million | 9.37 Million | - | 8.94 Million | -412.36 Million | 1.5 Million |
| Cost and Expenses | 282.37 Million | 273.44 Million | 271.81 Million | 264.68 Million | 252.41 Million | 246.23 Million |
| Operating Income | -213.13 Million | -212.45 Million | -216.34 Million | -206.23 Million | -605.82 Million | -188.14 Million |
| Interest Expense | 1.48 Million | 1.51 Million | 1.52 Million | 1.61 Million | 1.69 Million | 1.8 Million |
| Income Tax Expense | 12.67 Million | -286 Thousand | -3.18 Million | -300 Thousand | 42.19 Million | 573 Thousand |
| Earnings before Tax | -216.08 Million | -214.79 Million | -224.69 Million | -208.52 Million | -607.51 Million | -189.94 Million |
| Net Income | -212.45 Million | -199.82 Million | -204.61 Million | -193.73 Million | -632.58 Million | -173.68 Million |
| Earnings Per Share Basic | -2.31 | -2.17 | -2.22 | -2.11 | -6.87 | -1.89 |
| Earnings Per Share Diluted | -2.31 | -2.17 | -2.22 | -2.11 | -6.87 | -1.89 |
| Weighted Average Shares Outstanding | 91.97 Million | 92.11 Million | 92.04 Million | 91.81 Million | 92.07 Million | 92.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.97 Million | 92.11 Million | 92.04 Million | 91.81 Million | 92.07 Million | 92.02 Million |
| Gross Margin | 0.16 | 0.09 | -0.30 | 0.00 | 0.08 | 0.15 |
| EBIT Margin | -2.98 | -4.02 | -3.59 | -3.97 | -11.23 | -3.83 |
| Profit Margin | -3.34 | -4.24 | -3.69 | -4.24 | -12.23 | -4.01 |
| EBITDA | -189.14 Million | -189.27 Million | -199.17 Million | -181.73 Million | -580.93 Million | -165.85 Million |
| Earnings Before Tax Margin | -3.36 | -4.51 | -3.90 | -4.51 | -11.71 | -4.34 |
WDS
MAPB
GRC
MJD
FBU
PET